WOOJUNG BIO, Inc. (KOSDAQ:215380)
3,305.00
-265.00 (-7.42%)
At close: Mar 12, 2026
WOOJUNG BIO Market Cap
WOOJUNG BIO has a market cap or net worth of 60.67 billion as of March 13, 2026. Its market cap has increased by 121.30% in one year.
Market Cap
60.67B
Enterprise Value
109.90B
Revenue
37.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,305.00
Market Cap Chart
Since April 20, 2017, WOOJUNG BIO's market cap has increased from 44.42B to 60.67B, an increase of 36.59%. That is a compound annual growth rate of 3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 55.62B | 87.68% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 996.69B |
| DreamCIS | 131.00B |
| HLB bioStep | 105.59B |
| P&K Skin Research Center | 62.10B |
| C&R Research | 46.61B |
| DT&CRO CO. | 40.01B |
| SLS BIO | 26.89B |
| BioInfra | 18.07B |